At Kyperion, we acquire off-patent branded drugs from large-cap pharmaceutical companies to re-vitalize the products through our network in Asia. For newly approved drugs or pipeline in development, we seek exclusive licensing as well as offer innovative royalty financing solutions. Innovating for tomorrow, transforming lives today.VisionWe strive for excellence in our service, people, and portfolio and to be the preferred partner in the pharmaceutical industry.